Xenotransplantation is the transplantation of living cells, tissues, or organs from one species into another, and in practice it almost always means moving something from a pig into a human. The concept has been around for over a century, but only in the past few years have gene-editing tools made it realistic enough to attempt in living patients. Two people have received genetically modified pig hearts, several have received pig kidneys, and the results have been promising enough to reshape the conversation about organ shortages worldwide.
Why Pigs and Not Other Animals
Early xenotransplantation attempts in the twentieth century used primates. In the 1960s, a surgeon named Reemtsma transplanted chimpanzee kidneys into 13 patients, one of whom went back to work for nearly nine months before dying suddenly. The first heart transplant ever performed in a human used a chimpanzee heart in 1964, though that patient survived only about two hours.1PubMed Central. A brief history of cross-species organ transplantation Baboon livers were tried in the 1990s, with one patient surviving 70 days.2PubMed Central. A brief history of clinical xenotransplantation
Primates fell out of favor for several reasons. They are slow to breed, produce few offspring, and raise intense ethical concerns. Pigs, on the other hand, are anatomically and physiologically similar enough to humans that their organs are roughly the right size. Pig breeding is well established and cost-effective, and the wide variety of breeds means organ size can be matched to the recipient.3PubMed Central. Genetically Modified Pigs as Organ Donors for Xenotransplantation We already use pig heart valves in cardiac surgery, pigskin for burn grafts, and porcine insulin was the standard treatment for diabetes before synthetic versions arrived. The pig is not a perfect match for humans, but it is close enough to work with, and the practical advantages of raising pigs at scale are enormous.
The Immune Barrier That Blocked Progress for Decades
The central challenge of xenotransplantation has always been the immune system. When a pig organ enters a human body, the immune response is not just aggressive but catastrophic. Within minutes, human antibodies bind to a sugar molecule on pig cells called galactose-alpha-1,3-galactose, commonly shortened to alpha-Gal. This sugar sits on the surface of pig blood vessel cells in very high concentrations, and it triggers a chain reaction: antibodies bind, the complement system activates, and the blood vessels inside the organ are destroyed almost immediately.4PubMed. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies Blood clots form, the organ swells, and within minutes to hours the transplant is dead. This process, called hyperacute rejection, is far more violent than what happens when a human receives a mismatched human organ.
Humans carry these anti-pig antibodies from birth. They develop in infancy, probably in response to gut bacteria that carry the same sugar on their surfaces. Every human has them, and no amount of standard immunosuppression can overcome the sheer volume of antibody and complement activation that hits a pig organ.5PubMed Central. Immunobiological barriers to xenotransplantation For decades, this problem seemed nearly unsolvable.
How Genetic Engineering Changed the Equation
The breakthrough came from gene editing. If the alpha-Gal sugar is what triggers hyperacute rejection, removing it from the pig should reduce the immune attack. Researchers accomplished this by knocking out the gene responsible for producing alpha-Gal, known as GGTA1. But alpha-Gal is not the only sugar on pig cells that human antibodies recognize. Two others, called Neu5Gc and the Sda antigen, also provoke immune reactions. Using CRISPR-Cas9, scientists have now created “triple knockout” pigs missing all three of these problematic sugars. Testing on tissues from these pigs showed that alpha-Gal, Neu5Gc, and Sda were virtually undetectable, and human antibody binding dropped significantly in the heart, lungs, kidneys, and corneas.6PubMed Central. Antigenicity of tissues and organs from GGTA1/CMAH/β4GalNT2 triple gene knockout pigs
Removing the offending sugars is only half the strategy. The other half involves adding human genes to the pig. Humans carry proteins on the surface of their blood vessel cells that act as brakes on the complement system, preventing it from attacking the body’s own tissues. Pig cells lack the human versions of these proteins, so when human complement floods a pig organ, nothing holds it in check. By inserting genes for human complement regulatory proteins like CD46, CD55, and CD59 into the pig genome, researchers give pig cells a shield against human complement. Hearts from pigs carrying these human proteins survived significantly longer when transplanted into baboons compared to hearts from unmodified pigs.7Nature Medicine. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury Pigs engineered to express multiple human complement regulators at the same time show even greater protection.8PubMed Central. Complement networks in gene-edited pig xenotransplantation: enhancing transplant success and addressing organ shortage
The pigs now being used in clinical xenotransplantation carry ten or more genetic modifications: several gene knockouts to remove immune-provoking sugars, plus several inserted human genes to protect against complement attack and blood clotting. The level of genetic engineering involved is staggering, and it was simply not possible before tools like CRISPR made precise, multiplex gene editing routine.
Problems That Outlast Hyperacute Rejection
Solving hyperacute rejection was necessary but not sufficient. Once a pig organ survives the first hours, other problems emerge. One of the most stubborn is coagulation dysregulation. Even with the alpha-Gal gene deleted, pig organ transplants into primates almost always show blood clots forming inside the graft, and the recipient’s platelets get consumed at an alarming rate. This can spiral into a condition where the blood loses its ability to clot properly throughout the entire body. Pig liver transplants are especially dangerous in this regard: liver cells and the blood vessel cells lining the liver actively consume the recipient’s platelets through a process that does not even require the normal clotting cascade, leading to fatal bleeding within days.9PubMed Central. Controlling coagulation dysregulation in xenotransplantation
Another unexpected hurdle is organ overgrowth. Pig hearts, in particular, tend to keep growing after transplantation into primates, eventually becoming too large for the recipient’s chest. This is a species mismatch issue: pigs grow faster and larger than humans during the same time frame. One solution is to knock out the growth hormone receptor gene in donor pigs, which slows their overall growth. Research has shown that pig hearts with this modification grow less after transplantation, maintaining a more appropriate size for over six months without the need for additional drugs.10The Journal of Thoracic and Cardiovascular Surgery. The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donors Using these slower-growing donor pigs also allows researchers to pick animals that have passed the steepest phase of their growth curve, reducing the risk of overgrowth further.11PubMed. Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies
The Virus Question
Putting an animal organ into a human creates a potential bridge for animal viruses to cross into the human population. The virus that has received the most attention is porcine endogenous retrovirus, or PERV. Unlike a regular infection, PERVs are embedded in the pig’s own DNA. Every pig carries them, and they cannot be eliminated by raising pigs in clean facilities. Researchers confirmed that PERVs can infect human cells in the lab, and that once inside human cells, they can spread horizontally to other human cells.12PubMed Central. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9
The scale of the PERV problem is what made it seem so daunting: one commonly used pig cell line was found to carry 62 copies of the virus gene scattered across its genome. But in 2015, a team used CRISPR-Cas9 to disrupt all 62 copies simultaneously, reducing viral transmission to human cells by more than a thousandfold.13PubMed. Genome-wide inactivation of porcine endogenous retroviruses (PERVs) By 2017, the same group had produced live, PERV-free piglets through cloning, proving that the approach works at the whole-animal level.12PubMed Central. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9
PERVs are not the only infectious concern. Porcine cytomegalovirus, or PCMV, is a conventional virus that can be screened for and eliminated through careful breeding and early weaning of piglets. But when PCMV slips through and gets transmitted during a xenotransplant, the consequences are serious. In baboon recipients of pig hearts, PCMV transmission was associated with reduced transplant survival, elevated inflammatory markers, and disruption of the coagulation system.14Scientific Reports. Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival The virus appears to damage the blood vessel lining inside the transplanted organ and exhaust the recipient’s immune system.15PubMed Central. Reduction of the survival time of pig xenotransplants by porcine cytomegalovirus This finding has made PCMV screening a non-negotiable part of donor pig preparation.
What Has Actually Happened in Patients
The first person to receive a genetically modified pig heart as a permanent transplant was David Bennett, in January 2022. His heart functioned well for over 40 days. Then anti-pig antibodies began rising, and he died on day 60. The exact cause of death remains debated; his health was poor before the surgery, and he never fully recovered despite weeks of good graft function.16PubMed Central. The first clinical pig heart transplant: Was IVIg or pig cytomegalovirus detrimental to the outcome? A second pig heart was transplanted into a living patient in 2023. The heart initially worked well with excellent function, but it developed rapidly worsening heart failure starting around day 31, with wall thickening and loss of pumping ability. The patient chose comfort care after 40 days. Tissue analysis did not show immune cell invasion but instead pointed to capillary damage with swelling and early scarring, consistent with antibody-mediated injury.17Nature Medicine. Transplantation of a genetically modified porcine heart into a live human
Pig kidneys have been tested in brain-dead patients maintained on life support. In the first such experiment at NYU in 2021, a kidney from an alpha-Gal knockout pig began producing urine immediately after being connected. Over 54 hours of observation, the kidney showed no macroscopic signs of rejection.18PubMed Central. Genetically engineered pig kidney transplantation in a brain-dead human subject A subsequent pair of kidney transplants into brain-dead recipients showed impressive results: both kidneys began making urine within moments, creatinine levels dropped steadily, and urine output from the pig kidney was more than double what the recipient’s own kidneys had been producing. Biopsies taken repeatedly over 54 hours revealed no signs of hyperacute or antibody-mediated rejection.19PubMed. Results of Two Cases of Pig-to-Human Kidney Xenotransplantation Later pig-to-human kidney cases also demonstrated restored renal function, with one case showing daily urine output averaging 4,000 milliliters and stable creatinine levels over the first several days.20Cell Reports Medicine. Results of two cases of pig-to-human kidney xenotransplantation
These cases are proof-of-concept, not routine treatment. The kidneys functioned for hours to days in controlled settings. The hearts lasted weeks. Antibody-mediated rejection remains the barrier that ends these grafts, and strategies to overcome it are the immediate research priority.17Nature Medicine. Transplantation of a genetically modified porcine heart into a live human
Pig Islets for Diabetes
Xenotransplantation is not just about whole organs. One of its longest-running applications involves transplanting insulin-producing islet cells from pig pancreases into people with type 1 diabetes. The first clinical pig islet transplant was performed in 1993.2PubMed Central. A brief history of clinical xenotransplantation Because islet cells can be encapsulated in protective coatings that shield them from the immune system, they may not require the same heavy immunosuppression that whole organ transplants demand.
In one notable case, a patient with type 1 diabetes received alginate-encapsulated pig islets placed into his abdominal cavity. His daily insulin requirement dropped by about 30 percent within 12 weeks. When surgeons looked inside the abdomen 9.5 years later, they found capsules still present with live cells inside, some still producing small amounts of insulin.21PubMed. Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation More recent work has produced encapsulation devices that maintained blood sugar control in diabetic mice for over 200 days after receiving pig islets.22Cell Reports Methods. A porcine islet-encapsulation device that enables long-term discordant xenotransplantation in immunocompetent diabetic mice The appeal of this approach is clear: if you can protect pig islets well enough, you might treat diabetes without lifelong immunosuppressive drugs and without waiting for a human pancreas donor.
Keeping the Organ Alive Before Surgery
An underappreciated challenge is how pig organs are stored between harvesting and transplantation. Standard practice for human organs is static cold storage, essentially placing the organ on ice. It turns out pig kidneys are far more sensitive to this treatment than human kidneys. In primate studies, all pig kidneys preserved with standard cold storage experienced hyperacute rejection within 90 minutes of being connected to the recipient’s blood supply, even in recipients with low levels of anti-pig antibodies. In contrast, kidneys preserved using hypothermic machine perfusion, which slowly pumps cold preservation fluid through the organ, reperfused without injury and maintained function for more than 14 days.23Communications Medicine. Hypothermic machine perfusion prevents hyperacute graft loss in pig-to-primate kidney xenotransplantation after 5-hours of cold Ischemia This finding suggests that the way we store organs may need to be fundamentally rethought for xenotransplantation, since practices that work fine for human organs could doom pig organs before the surgeon even begins.
Immunosuppression Beyond Gene Editing
Even with ten or more genetic modifications in the donor pig, human recipients still need immunosuppressive drugs. The regimens used in the recent pig heart cases were more intense than what typical human organ recipients take. One area of active research focuses on blocking the interaction between two immune signaling molecules called CD40 and CD154. This communication channel is central to how T cells mount an attack on foreign tissue. Blocking it has been shown to suppress donor-reactive immune cells and extend graft survival in both allotransplant and xenotransplant settings.24PubMed Central. CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation Several antibodies targeting this pathway are now in development. Getting immunosuppression right is arguably as important as getting the genetics right, because the clinical pig heart cases both ended due to immune-mediated injury despite sophisticated genetic modifications.
Ethics, Religion, and Public Perception
Using pigs as organ factories raises ethical questions that go beyond standard animal welfare concerns. Animal rights advocates object on grounds of intelligence, sentience, and capacity for suffering. Others who accept pigs as food still wonder whether harvesting their living organs crosses a different ethical line.25The Annals of Thoracic Surgery. Pig-to-Human Heart Transplantation: Culmination of Technology and Ingenuity Proponents counter that genetic modifications to donor pigs are carefully designed to avoid affecting the animals’ health, and that the potential benefit to patients is lifesaving.26Frontiers in Immunology. Ethical and legislative advances in xenotransplantation for clinical translation: focusing on cardiac, kidney and islet cell xenotransplantation
Religious considerations add another layer. Jewish and Muslim dietary law prohibits consuming pork, which initially raised concerns about whether transplanting pig organs would be acceptable. In practice, leaders in both traditions have generally found that the imperative to preserve human life takes precedence.25The Annals of Thoracic Surgery. Pig-to-Human Heart Transplantation: Culmination of Technology and Ingenuity For patients themselves, the psychological dimension is real. A survey of transplant patients found that about 23 percent associated receiving an animal organ with considerable or severe emotional stress, compared to only 3 percent for receiving a human organ.27PubMed. Attitude of patients toward transplantation of xenogeneic organs Informed consent for xenotransplantation trials must cover not only the medical risks but also the experimental nature of the procedure and the possibility of lifelong monitoring for cross-species infections.26Frontiers in Immunology. Ethical and legislative advances in xenotransplantation for clinical translation: focusing on cardiac, kidney and islet cell xenotransplantation
Regulation and the Road to Clinical Trials
Because xenotransplantation involves a living biological product from another species, it sits at the intersection of drug regulation, device regulation, and transplant policy. The U.S. Food and Drug Administration issued formal guidance in 2003 covering everything from the pathogen-free status of donor animals to record-keeping requirements for both donor pigs and human recipients. The European Medicines Agency followed with its own guideline on xenogeneic cell therapy products in 2009.28International Journal of Surgery. Regulatory aspects of clinical xenotransplantation The World Health Organization has encouraged member nations to establish their own regulatory bodies to govern clinical xenotransplantation studies.29PubMed Central. Regulatory barriers to xenotransplantation
In practice, xenotransplantation is currently regulated more like a pharmaceutical product than a surgical procedure. Frameworks require evidence of safety and efficacy from preclinical studies, risk management protocols for infectious outbreaks, and specific conditions regarding the safety of source animals and the manufacturing process.30PubMed. Regulation of Clinical Xenotransplantation: A Reappraisal of the Legal, Ethical, and Social Aspects Involved The cases performed so far have operated under compassionate use or expanded access provisions, not formal clinical trials. Getting from where we are now to a standard FDA-approved clinical trial will require demonstrating longer graft survival in pre-clinical models and establishing clear safety data on infection risk.
What It Might Cost
The economics of xenotransplantation are complicated. On one hand, keeping patients alive while they wait for a human organ is enormously expensive, especially if chronic dialysis or mechanical heart support is required. Xenotransplantation could theoretically eliminate wait times and allow transplants before patients deteriorate further, saving substantial costs on pretransplant care. On the other hand, genetically engineered pigs raised in biosecure facilities are not cheap, and the limited evidence so far on long-term graft survival makes it hard to argue that xenotransplantation is currently cost-effective.31PubMed Central. Considering the Risks and Costs of Solid Organ Xenotransplantation One preliminary analysis estimated that savings from eliminating pretransplant care for individual patients could be significant, but those savings may be offset by the cost of producing the gene-edited pig organ itself.32PubMed. How Much Will a Pig Organ Transplant Cost? A Preliminary Estimate of the Cost of Xenotransplantation Versus Allotransplantation in the USA The cost picture will almost certainly shift as the technology matures and production scales up, but for now, no one should expect pig organs to be a budget solution to the transplant crisis.